- Poster presentation
- Open Access
Long standing cyanosis in congenital heart disease does not cause diffuse myocardial fibrosis
© Kharabish et al.; licensee BioMed Central Ltd. 2014
- Published: 16 January 2014
- Congenital Heart Disease
- Late Gadolinium Enhancement
- Inferior Wall
- Post Contrast
- Cyanotic Congenital Heart Disease
The assumption of the presence of diffuse myocardial fibrosis in long standing cyanotic congenital heart disease (CHD) inspired us to noninvasively determine the myocardial extracellular volume (ECV) using contrast CMR (T1 mapping).
T1 maps were measured pre and 3-10 minutes after the infusion of 0.15 mmol/kg of gadolinium on 25 subjects. Seven adult patients with longstanding cyanotic CHD and no previous surgical history (aged 16-53 yrs and oxygen saturations of 69-90%), nine normal subjects (aged 14-49 yrs), and nine patients with previously cyanotic CHD after total repair during which a heart lung machine was used (aged 2 months-58 yrs). Images were obtained in a mid-ventricular short axis plane. Late gadolinium enhancement using the phase sensitive inversion recovery (PSIR) sequence was performed to exclude scar areas. The T1 values were measured in two areas of the myocardium, in the septum and in the left ventricular posterior or inferior wall, such that same areas were assessed in every patient in the pre and post contrast T1 scan. ECV was calculated according to (1-hematocrit)*(ΔR1 myocardium/ΔR1 blood).
Patients with cyanosis had significantly lower ECV percentage than the previously cyanotic patients after total repair (septum: 22 ± 2% vs 35 ± 12%, p = 0.01; LV wall: 22 ± 2% vs 30 ± 7%, p = 0.02, respectively). No significant differences were found between patients with cyanosis and normal controls (septum: 22 ± 2% vs 24 ± 1%, p = 0.14; LV wall: 22 ± 2% vs 24 ± 2%, p = 0.21, respectively). ECV values were significantly different between the three groups in both septum and LV wall (f = 0.007 and f = 0.02, respectively).
Long standing cyanosis in congenital heart disease without cardiac surgery does not cause diffuse myocardial fibrosis or expansion of the myocardial extra cellular volume.
All authors have no conflict of interest.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.